Kyntra Bio (KYNB) EV to FCF (2014 - 2026)
Kyntra Bio's (KYNB) quarterly EV to FCF came in at 9.84 in Q2 2026, up 727.64% year-over-year from 1.19 in Q2 2025, and up 256.65% quarter-over-quarter from 2.76 in Q1 2026.
Analysis
Kyntra Bio (KYNB) EV to FCF (2014 - 2026) Analysis & Trends
Kyntra Bio has disclosed EV to FCF across 13 years of filings, most recently posting 9.84 for Q2 2026.
- In Q2 2026, EV to FCF rose 727.64% year-over-year to 9.84; the TTM figure through Jun 2026 stood at 1.03 (up 262.3% YoY), while the FY2025 annual figure was 6.64, up 2664.12% from the prior year.
- EV to FCF came in at 9.84 for Q2 2026 at Kyntra Bio, up from 2.76 in the prior quarter.
- In the past five years, EV to FCF ranged from a high of 37.38 in Q3 2025 to a low of 70.52 in Q1 2022.
- Average EV to FCF over 5 years is 3.46, with a median of 1.24 recorded in 2024.
- Year-over-year, EV to FCF slumped 240.42% in 2022 and jumped 727.64% in 2026.
- Over 5 years, EV to FCF stood at 20.56 in 2022, then surged by 133.15% to 6.81 in 2023, then plunged by 84.07% to 1.09 in 2024, then soared by 60.65% to 1.74 in 2025, then soared by 464.15% to 9.84 in 2026.
- Per Business Quant data, the three most recent EV to FCF figures were 9.84 in Q2 2026, 2.76 in Q1 2026, and 1.74 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn |
| 10 | Kyntra Bio | 32.08 Mn | 32.08 Mn | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.84 |
| Mar 31, 2026 | 2.76 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 37.38 |
| Jun 30, 2025 | 1.19 |
| Mar 31, 2025 | 4.70 |
| Dec 31, 2024 | 1.09 |
| Sep 30, 2024 | 8.19 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | -1.31 |
| Dec 31, 2023 | 6.81 |
| Sep 30, 2023 | 1.70 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | -14.36 |
| Dec 31, 2022 | -20.56 |
| Sep 30, 2022 | -15.80 |
| Jun 30, 2022 | -16.83 |
| Mar 31, 2022 | -70.52 |
| Dec 31, 2021 | -16.40 |
| Sep 30, 2021 | 11.25 |